U.S. Sets Record for Worst Avian Flu Outbreak, With 50.5M+ Birds Dead

Ultragenyx Pharmaceutical (NASDAQ:RARE) reported quarterly losses of $(2.26) per share. This is a 24.86 percent decrease over losses of $(1.81) per share from the same period last year. The company reported $89.34